Cargando…
P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL.
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431115/ http://dx.doi.org/10.1097/01.HS9.0000970512.51896.93 |
_version_ | 1785091123457294336 |
---|---|
author | Vesole, David H. Berdeja, Jesus Matous, Jeffrey Trudel, Suzanne Schade, Henning Munster, Pamela Berkeley, Savannah Sun, Benjamin Martin, Tom |
author_facet | Vesole, David H. Berdeja, Jesus Matous, Jeffrey Trudel, Suzanne Schade, Henning Munster, Pamela Berkeley, Savannah Sun, Benjamin Martin, Tom |
author_sort | Vesole, David H. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104311152023-08-17 P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL. Vesole, David H. Berdeja, Jesus Matous, Jeffrey Trudel, Suzanne Schade, Henning Munster, Pamela Berkeley, Savannah Sun, Benjamin Martin, Tom Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431115/ http://dx.doi.org/10.1097/01.HS9.0000970512.51896.93 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Vesole, David H. Berdeja, Jesus Matous, Jeffrey Trudel, Suzanne Schade, Henning Munster, Pamela Berkeley, Savannah Sun, Benjamin Martin, Tom P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL. |
title | P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL. |
title_full | P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL. |
title_fullStr | P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL. |
title_full_unstemmed | P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL. |
title_short | P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL. |
title_sort | p902: isatuximab, weekly carfilzomib and dexamethasone as salvage therapy for rrmm; interim results from a phase 2 trial. |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431115/ http://dx.doi.org/10.1097/01.HS9.0000970512.51896.93 |
work_keys_str_mv | AT vesoledavidh p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial AT berdejajesus p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial AT matousjeffrey p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial AT trudelsuzanne p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial AT schadehenning p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial AT munsterpamela p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial AT berkeleysavannah p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial AT sunbenjamin p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial AT martintom p902isatuximabweeklycarfilzomibanddexamethasoneassalvagetherapyforrrmminterimresultsfromaphase2trial |